Literature DB >> 8263101

High-performance liquid chromatographic assay for human liver microsomal omeprazole metabolism.

T Andersson1, P O Lagerstrøm, J O Miners, M E Veronese, L Weidolf, D J Birkett.   

Abstract

Assays for the measurement of omeprazole metabolites in plasma and urine have been reported, but when applied to the determination of omeprazole metabolites formed by human liver microsomal incubations there were obvious limitations in sensitivity. The present high-performance liquid chromatographic (HPLC) assay, which comprises extraction, evaporation and reconstitution, is several-fold more sensitive with a limit of detection of approximately 2 pmol (2 nM in incubate) for omeprazole sulphone and 25 pmol (25 nM in incubate) for hydroxyomeprazole. Extraction efficiency is essentially quantitative and is highly reproducible (coefficient of variation = 2.1% for both metabolites). The assay is linear over a wide range of concentrations and the formation of the metabolites is linear with respect to both time (to 15 min) and protein concentration (to 1.5 mg/ml). Two minor metabolites, one of which was identified tentatively as 5-O-desmethylomeprazole, were also formed by human liver microsomes and could be determined by this method. Preliminary studies of the formation of omeprazole sulphone and hydroxyomeprazole showed that the formation kinetics in human liver microsomes were biphasic for both metabolites, suggesting that at least two different cytochrome P450 isoforms are involved in their formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263101     DOI: 10.1016/0378-4347(93)80119-o

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.

Authors:  T Andersson; J O Miners; M E Veronese; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

2.  Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers.

Authors:  Sunny Park; Yang Jin Hyun; Yu Ran Kim; Ju Hyun Lee; Sunae Ryu; Jeong Mi Kim; Woo Yong Oh; Han Sung Na; Jong Gu Lee; Doo Won Seo; In Yeong Hwang; Zewon Park; In Jin Jang; Jaeseong Oh; Seung Eun Choi
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

3.  Spectrophotometric determination of certain benzimidazole proton pump inhibitors.

Authors:  A A Syed; Ayesha Syeda
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.